Sealed Air Corporation announces that it has completed an acquisition of Virox Technologies’ Accel® brand and its related healthcare businesses in the United States and Canada.
The acquired assets include the brand, the current healthcare business and existing customer relationships. Through its Diversey Care business, Sealed Air has had a long standing exclusive, global relationship with Virox and this new arrangement will enhance Diversey Care’s marketing of Virox’s proprietary Accelerated Hydrogen Peroxide® (AHP®) technology. In addition to increased focus on healthcare surface cleaning and disinfection applications, Diversey Care continues to provide all the benefits of AHP to the broader institutional markets such as education, government, facility management, retail and food service.
“We see a unique opportunity to leverage Virox’s patented technology and Professional and Technical Services (PTS) model around the world to deliver thought leadership in the cleaning and disinfecting arena,” says Ilham Kadri, president of Sealed Air’s Diversey Care Division. “Their PTS model leveraged with our sales coverage, application expertise, and global distribution will create an environment for the success of our AHP- based solutions in the Oxivir® brand globally.”
AHP is a patented, synergistic blend of commonly used, safe ingredients, that when combined with low levels of hydrogen peroxide dramatically increase its disinfecting and cleaning ability. It provides the unique benefits of speed and efficacy, while being gentle on people, surfaces and the environment.
Virox CEO Randy Pilon states, “Virox has a long standing relationship with Diversey Care and our combined healthcare business now puts Diversey in a leading position for knowledge-based solutions in surface disinfection in the healthcare sector in Canada. The plan is to replicate this success in the United States and become the infection prevention resource to healthcare professionals so that all the sectors supported by Diversey Care will feel confident in choosing their infection prevention solutions.”
Financial terms of the transaction were not disclosed. Sealed Air does not expect the transaction to be material to its consolidated financial position or results of operations.
Source: Sealed Air Corporation
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.